iRhythm Holdings, Inc. (IRTC)
123.72
+1.24
(+1.01%)
USD |
NASDAQ |
Sep 03, 15:44
iRhythm Holdings Research and Development Expense (Annual) : 84.61M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 84.61M |
| December 31, 2024 | 71.46M |
| December 31, 2023 | 60.24M |
| December 31, 2022 | 46.61M |
| December 31, 2021 | 38.67M |
| December 31, 2020 | 41.33M |
| December 31, 2019 | 37.30M |
| Date | Value |
|---|---|
| December 31, 2018 | 20.86M |
| December 31, 2017 | 13.34M |
| December 31, 2016 | 7.15M |
| December 31, 2015 | 6.349M |
| December 31, 2014 | 5.698M |
| December 31, 2013 | 3.664M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Accuray, Inc. | 37.75M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 65.85M |
| ResMed, Inc. | 378.28M |
| Rockwell Medical, Inc. | 0.00 |